Elizabeth Blackburn
Showing 1–5 of 5 transcripts.
- Milken Institute57 min
Want to Live to a Healthy 100?
Paul Irving, Elizabeth Blackburn, Dan Buettner, Laura Deming, Arianna Huffington
Panelists including Dan Buettner, Liz Blackburn, and Arianna Huffington synthesized data on Blue Zone environments, telomere biology, and stress management to redefine longevity as an ecosystem driven by social connection, plant-based diets, and natural movement rather than individual willpower. The discussion highlighted that while specific biological markers like telomere length strongly predict mortality, systemic factors such as zip code and access to healthy environments create a twenty-year life expectancy gap that current healthcare spending fails to address. To bridge this divide, the experts advocated for a policy shift toward the "Wisdom Quotient" and environmental redesign, aiming to compress morbidity and democratize healthspan across all demographics.
- Milken Institute1h 2m
A Conversation with Angela Ahrendts, Part 2: A Conversation with Elizabeth Blackburn
Angela Ahrendts, Elizabeth Blackburn, Lucy Parker, Joon Yun
Apple Retail is executing a strategic transformation led by Angela Ahrendts that redefines physical locations as community town squares and learning centers to address social isolation and boost employee retention. The initiative involves rolling out a "Today at Apple" curriculum across 419 stores, introducing specialized Creative Pro roles to deliver free education in fields like coding and art while supporting local entrepreneurship. This approach integrates retail as a service product that measures social impact alongside financial returns, successfully raising employee retention to 82 percent. Concurrently, Elizabeth Blackburn's research demonstrates that telomere length, a marker of cellular aging, is malleable and responsive to lifestyle interventions such as brief daily exercise, sleep, and stress management. Her findings highlight that positive social connections and a sense of purpose can significantly buffer telomere shortening, reframing aging as an opportunity to maximize health span rather than an inevitable decline.
- Milken Institute58 min
Will You Live to a Healthy 100?
Francis Collins, Nir Barzilai, Elizabeth Blackburn, Pinchas Cohen, Joon Yun
A panel of researchers and investors shifts the longevity paradigm from extending chronological lifespan to maximizing healthspan by treating aging as a primary risk factor for chronic disease. Key figures such as Nir Barzilai, Elizabeth Blackburn, and Jun Jung highlighted actionable strategies including genetic insights from centenarians, the management of senescent cells, and the development of a $7 trillion market focused on restoring homeostatic capacity. These efforts are culminating in the imminent TAME clinical trial, which aims to establish aging as an FDA-recognized disease and unlock pharmaceutical investment for drugs like Metformin and Rapamycin to extend human health by two years.
- Milken Institute31 min
MIc'd Up | Part 2: A Conversation with Elizabeth Blackburn
Salk Institute President Dr. Elizabeth Blackburn discusses the biological mechanisms of aging and telomere maintenance with host Jun Yun, framing the extended human lifespan as an opportunity to maximize health span rather than a inevitable decline. The dialogue details how specific lifestyle interventions—including brisk daily exercise, seven hours of sleep, and cognitive reframing of stress—directly influence telomere length to mitigate risks of chronic diseases like Alzheimer's and diabetes. By integrating molecular biology with health psychology, Blackburn argues that dynamic gene expression allows individuals to actively shape their cellular health and extend their years of vitality.
- Milken Institute1h 10m
Lunch Program | This Changes Everything: How Technology Is Revolutionizing Medicine
Margaret Anderson, Mike Milken, Jack Gilbert, Elizabeth Blackburn, Vadim Bachman, Nina Tandon, Juan Enriquez, Mike Cloughton
Based at the Milken Institute, Faster Cures convenes leading scientists like Dr. Elizabeth Blackburn and Juan Enriquez to advocate for a systemic overhaul of biomedical research that addresses the critical gap between 10,000 known diseases and the 500 treatments currently in development. The event highlights transformative breakthroughs in genomics, microbiome manipulation, and synthetic biology, demonstrating how technologies such as nanocytology and living implants are shifting medical paradigms toward early detection and regenerative solutions. By integrating public policy advocacy with these scientific advancements, the organization aims to optimize the research ecosystem and accelerate the delivery of cures for conditions ranging from cancer to neurodegenerative disorders.